Multidisciplinary Engagement in Major Depressive Disorder Care:  A Focused Look at the Role, Identification, and Treatment of Cognitive Impairment
Audiocast Audiocast

Multidisciplinary Engagement in Major Depressive Disorder Care: A Focused Look at the Role, Identification, and Treatment of Cognitive Impairment


Released:
8/28/19
Expires:
8/27/20

Maximum Credits:

0.75
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

Audiocast Audiocast
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.
Released:
8/28/19

Expires:
8/27/20

Maximum Credits:
0.75
Audiocast Audiocast
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

Released:
8/28/19
Expires:
8/27/20


Maximum Credits:
0.75


Overview: Join experts Michael Thase, MD, and William Clay Jackson, MD, DipTh, FAAFP, in an engaging online CME activity on the identification and treatment of major depressive disorder (MDD) in the primary care setting. Faculty provide an overview of MDD, review validated screening tools, examine its relationship with cognitive dysfunction, and explain guideline recommendations for its treatment. In addition, personalized management strategies are explored through a series of case-based scenarios designed to highlight key points in the assessment and treatment of MDD.

CME Information:

Faculty
Michael E. Thase, MD
Professor of Psychiatry
Department of Psychiatry
Perelman School of Medicine, University of Pennsylvania
Corporal Michael J. Crescenz Veterans Affairs Medical Center
Philadelphia, PA
 
William Clay Jackson, MD, DipTh, FAAFP
Clinical Assistant Professor, Department of Family Medicine and Psychiatry
Associate Director, Palliative Medicine Fellowship
University of Tennessee College of Medicine
Memphis, TN

Activity Planners
Susan Kuhn, MHSc
Manager, Educational Strategy and Content
Med-IQ
Baltimore, MD
 
Samantha Gordon
CME Specialist
Med-IQ
Baltimore, MD
 
Kathryn Schaefer, MSN, RN, CPHRM
Senior Manager, Accreditation and Compliance
Med-IQ
East Lansing, MI

Learning Objectives
Upon completion, participants should be able to:

  • Integrate clinical recommendations and practical methods to screen for depression in the primary care setting
  • Describe the current understanding of the relationship between depression and cognitive impairment and the use of cognitive assessment tools in practice
  • Describe depression treatment and monitoring strategies that consider individual patients’ treatment goals

Target Audience
This activity is intended for primary care physicians, nurse practitioners, physician assistants, and nurses.

Statement of Need
Depression is an increasingly common and complex disease for which primary care providers are uniquely positioned to provide effective care. However, to have a significant effect on their patients’ lives, primary care clinicians must be adept at conducting timely depression screening as well as developing individualized and effective treatment plans. Goals for depression treatment must extend beyond traditional, provider-defined improvement and include patient preferences and societal expectations. Achieving these goals is frequently hampered by cognitive impairments that persist even after providers believe their patients have attained remission. For these reasons, primary care clinicians must be able to better identify depression, determine when cognitive function is a concern, develop appropriate strategies for individualizing treatment, and create monitoring plans that allow for timely adjustments to care.

Providership Statement
Provided by Med-IQ.

Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Med-IQ designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Med-IQ is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
 
This nursing activity has been approved for up to 0.75 contact hour.
 
Physician assistants and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.

Instructions to Receive Credit
To receive credit, read the introductory CME/CE material, listen to the audiocast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
 
Initial Release Date: August 28, 2019
Expiration Date: August 27, 2020
Estimated Time to Complete This Activity: 45 minutes

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation. 

William Clay Jackson, MD, DipTh, FAAFP
Consulting fees/advisory boards: Allergan, Inc.Genentech, Otsuka America Pharmaceutical, Inc., Sunovion Pharmaceuticals Inc.

Michael E. Thase, MD
Consulting fees/advisory boards: ACADIA Pharmaceuticals Inc., Akili Interactive Labs, Inc., Alkermes, Allergan, Inc., Forest Laboratories, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Lundbeck, Naurex Inc., Otsuka America Pharmaceutical, Inc.

Susan Kuhn, MHSc
Spouse: Ownership interest (stocks/stock options – excluding mutual funds): Illumina, Johnson & Johnson, Viking Therapeutics

The peer reviewers and other activity planners have no financial relationships to disclose.

Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, Med-IQ has a policy to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.

Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.

Contact Information        
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email info@med-iq.com.

System Requirements

Desktop

Mobile

  • Operating system - Med-IQ supports the current operating system, plus two prior releases:
    • Android (eg, Samsung Galaxy)
    • Apple (eg, iPhone/iPad)
  • Browsers - Med-IQ supports the default browser for the applicable operating system release, plus two prior releases:
    • Android (Chrome)
    • Apple (Safari)

Applications & Software

For technical assistance, please refer to our Support Manual.

Disclaimer
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy policy, please visit: www.med-iq.com/privacy-policy.html.

ArcheMedex Privacy Policy
https://miq.arche.services/privacy-policy

Acknowledgment of Commercial Support
This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Lundbeck.

Copyright
© 2019 Med-IQ, Inc.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email info@med-iq.com. For technical assistance, please refer to our support manual.

We recently updated our Privacy Notice and Terms of Use.